Communiqués Vitrolife AB OTC Markets

Actions

Temps Différé OTC Markets Autres places de cotation 20:13:11 01/11/2023			Varia. 5j.	Varia. 1 janv.
13,3 ^USD	+16,16%		-.--%	-.--%

22/05	Le suédois Vitrolife finalise l'achat du groupe de logiciels eFertility	MT
22/05	Vitrolife AB (publ) (OM:VITR) a acquis Stb Zorg B.V.	CI

Vitrolife : 4 juni 2024, Handelsbanken Nordic Small & Mid Cap Seminar 2024 in Stockholm	04/06	PU
Vitrolife AB (publ) completes the acquisition of eFertility	22/05	AQ
Vitrolife AB (publ) acquires eFertility	02/05	AQ
Vitrolife : App 3 Annual report	25/04	PU
Report from Annual General Meeting of Vitrolife AB (publ)	25/04	AQ
Vitrolife Q1 update - Entering 2024 with low growth	22/04	AQ
Vitrolife : Item 8b Auditor statement remuneration	19/04	PU
Interim report Q1, 2024: Strong growth in APAC and solid margins	18/04	AQ
Correction: Notice to attend the Annual General Meeting of Vitrolife AB (publ)	04/04	AQ
Conference call interim report	04/04	AQ
Vitrolife : Item 18 proposal for LTIP 2024	02/04	PU
Vitrolife : Item 18 Appendix 1 to proposal for LTIP 2024	02/04	PU
Vitrolife Group Annual and Sustainability Report 2023	27/03	AQ
Vitrolife : Notice Annual General Meeting Vitrolife AB 2024	27/03	PU
Notice to attend the Annual General Meeting of Vitrolife AB (publ)	26/03	AQ
Vitrolife : 6 March 2024, Carnegie Healthcare Seminar Stockholm	06/03	PU
Vitrolife Q4 - Strong margins and gradually improving Genetic Services	05/02	AQ
Fourth quarter and full year report, 2023: Continued growth with margin expansions	02/02	AQ
Conference call full year report 2023	24/01	AQ
Vitrolife Group makes an impairment charge of SEK 4.3 billion relating to Igenomix and provides preliminary financials for the fourth quarter 2023	23/01	AQ

Aucun résultat pour cette recherche

Vitrolife AB (publ) : Pionnier de la fécondation in vitro

Le 25 juillet 2023 à 10:20